InterCure: True International Cannabis Play
InterCure offers a pure play on the European cannabis market with a focus on Israel. The company went public via a SPAC in April and now trades below the PIPE price at only $8. The stock is cheap at only 2x EV/'22 sales targets. This idea was discussed in more depth with members of my private investing community, Out Fox The Street. Learn More » The cannabis market is ripe with investment opportunities whether in the U.S. or Canada, but very few good investments exist for companies focused outside of North America. After closing a SPAC deal, InterCure ( OTCPK:IRCLF ) offers an impressive opportunity to invest in European growth via a small Israeli company. The stock is a solid buy considering the company doesn't come with an expensive price tag like most Canadian cannabis companies playing in European cannabis markets. Read the full article on Seeking Alpha. Disclosure: No position mentioned. Please review the disclaimer page for more details. Updat...